Global Sales of Lung Cancer Therapeutics are reach a industry valuation of USD 74.1 billion by 2031 – Genentech (F. Hoffmann-La Roche Ltd), Eli Lilly and Company, Celgene Corporation, AstraZeneca
The global lung cancer therapeutics market was valued at USD 18.3 billion in 2021 and it is anticipated to grow further till USD 74.1 billion by 2031, …